Hyperbaric oxygen therapy helps reduce lymphedema (breast cancer-related)

A prospective observational study was conducted on 10 patients with lymphedema (breast cancer related — BCRL). Bioimpedance spectroscopy (a relatively new diagnostic tool for evaluating the severity of the lymphedema) confirmed the benefits of Hyperbaric oxygen therapy alongside conventional therapy <view study>

Previous
Previous

29 year old female with stage 4 breast cancer responds successfully to combination therapy involving hyperbaric oxygen therapy

Next
Next

Hyperbaric preconditioning and cisplatin-induced peripheral neuropathy